Press Release FeedGet the RSS feed
Menu

Business Wire

FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes

Business Wire

  • One drop works to significantly reduce redness, with results lasting up to 12 hours1

  • Lasts up to 50% longer than Lumify1-2,*

  • Expands Alcon's portfolio of consumer eye care solutions and will be available in major retailers nationwide and online in the coming months

GENEVA, October 16, 2026--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that the U.S. Food and Drug Administration (FDA) has approved BRYTLY® Redness Reliever Eye Drops. With one drop, BRYTLY works in just one minute to significantly reduce redness and delivers up to 12 hours of whiter, brighter-looking eyes.1 Additionally, BRYTLY lasts up to 50% longer than Lumify.1-2,* The approval brings a differentiated new option to the over the counter (OTC) redness-relief category and expands Alcon's portfolio of trusted consumer eye care products.

Beauty and wellness routines are increasingly converging, with consumers looking for products that combine visible results, clinical validation and everyday convenience. Research has also found that visible eye redness can influence perceptions of healthiness and attractiveness, creating new relevance for the eyes as part of an overall appearance and wellness routine.3 BRYTLY brings a clinically proven option to this evolving space, by reducing redness and helping eyes look whiter and brighter with results that can last throughout the day, up to 12 hours.

"Consumers invest in products that help them look and feel their best, and the appearance of their eyes can be an important part of that," said Jonathan Balch, General Manager, Ocular Health & Pharmaceuticals, Alcon. "This FDA approval marks an exciting milestone for Alcon. With BRYTLY, we're bringing Alcon's trusted eye care expertise to consumers who want to reduce eye redness and want their eyes to look whiter and brighter. BRYTLY is designed to deliver simple, long-lasting redness reduction that can help consumers feel confident in how their eyes look throughout the day."

BRYTLY contains no bleaches or dyes and is clinically proven to be safe and effective when used as directed.1 Studies also demonstrated a low risk of redness rebound and tachyphylaxis when used as directed.4-5

"When patients ask about eye whiteners, they want a product they can trust to work effectively and fit into their day," said Selina McGee**, founder and chief optometrist of Bespoke Vision in Edmond, Oklahoma. "BRYTLY gives Eye Care Professionals a clinically proven option to recommend, with demonstrated safety and efficacy and long-lasting redness reduction from a single drop."

  1. FinanceAlign Technology, Inc.Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent CourtCompanies: Align TechnologySAN JOSE, Calif. & TEMPE, Ariz., October 17, 2026--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, welcomes the decision of the Unified Patent Court ("UPC") finding that aligner syst
  2. AISyncra and Neumetry Partner to Build AI-Powered Readiness Platform for Teenage Athletes and Their CoachesSmart ring data meets FDA-cleared physiological AI to help coaches see which athletes are ready to compete, and which need rest LAS VEGAS & SAN JOSE, Calif., October 17, 2026--Syncra Labs Inc., maker of the Syncra smart ring, and Neumetry Medical, Inc., developer of an FDA-cleared predictive health pla
  3. HealthcareAIDS Healthcare FoundationAHF Commemorates 40 Years of Global Impact During Annual World AIDS Day Concert Celebration Featuring Ricky MartinLOS ANGELES, October 16, 2026--AIDS Healthcare Foundation (AHF) , the world's largest, non-profit public health organization providing direct HIV/ADS services to over 3.3 million clients across the globe, will celebrate 40 years of impact during its annual World AIDS Day concert commemoration. Continu
  4. Real estateKBRA Assigns Preliminary Ratings to Angel Oak Mortgage Trust 2026-6 (AOMT 2026-6)NEW YORK, October 16, 2026--KBRA assigns preliminary ratings to ten classes of mortgage-backed certificates from Angel Oak Mortgage Trust 2026-6 (AOMT 2026-6), a $250.6 million non-prime RMBS transaction. The underlying collateral, comprised of 381 residential mortgages, and includes a meaningful conce
  5. FinanceUL SolutionsUL Solutions Warns of GFCI and Duplex Wall Outlets Modified by Third Parties to Include Built-in CamerasAfter manufacturing, third parties added built-in cameras to the wall outlets; UL Solutions did not evaluate the modified products and recommends that they be immediately removed from service and discarded. NORTHBROOK, Ill., October 16, 2026--UL Solutions (NYSE: ULS), a global leader in applied safety
  6. Port Houston Regular Commission Meetingto Be Held on Wednesday, October 21, 2026 HOUSTON, October 16, 2026--The Port Commission of the Port of Houston Authority will hold its Regular Monthly Meeting on Wednesday, October 21, 2026, beginning at 9:15 a.m. in the boardroom of the Port Houston Authority Administrative Building, located at 2960